In COVID-19, a sustained decrease in CD4+ and CD8+ T cells, especially CD8+ T cells, is observed, despite an increase in IL-6, IL-10, IL-2, IFN-γ levels, and neutrophil counts. The gene discussed is CD8A; the disease is COVID-19.